Get the Stockscreener App
15.58
1.33%
-0.21
Pre-market:
16.15
0.57
+3.66%
Personalis Inc stock is traded at $15.58, with a volume of 12.75M.
It is down -1.33% in the last 24 hours and up +60.78% over the past month.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
See More
Previous Close:
$15.79
Open:
$15.5
24h Volume:
12.75M
Relative Volume:
3.82
Market Cap:
$1.63B
Revenue:
$64.52M
Net Income/Loss:
$-95.55M
P/E Ratio:
-15.32
EPS:
-1.0169
Net Cash Flow:
$-84.65M
1W Performance:
+6.35%
1M Performance:
+60.78%
6M Performance:
+57.53%
1Y Performance:
+143.06%
1-Day Range:
$14.52
$16.12
1-Week Range:
$13.52
$16.15
52-Week Range:
$3.84
$16.15
Personalis Inc Stock (PSNL) Company Profile
Name
Personalis Inc
Sector
Industry
Phone
650-752-1300
Address
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
15.58 | 1.63B | 64.52M | -95.55M | -84.65M | -1.0169 |
TMO
Thermo Fisher Scientific Inc
|
543.19 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
205.01 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
576.07 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
269.83 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
136.10 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-15-25 | Initiated | Guggenheim | Buy |
| Mar-17-25 | Initiated | Craig Hallum | Buy |
| Feb-06-23 | Upgrade | Needham | Hold → Buy |
| Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-03-21 | Downgrade | Needham | Buy → Hold |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-20-21 | Reiterated | Needham | Buy |
| May-06-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-28-21 | Initiated | Truist | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-12-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Aug-27-20 | Initiated | H.C. Wainwright | Buy |
| Aug-18-20 | Initiated | Needham | Buy |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Initiated | BofA/Merrill | Neutral |
| Jul-15-19 | Initiated | Cowen | Outperform |
| Jul-15-19 | Initiated | Morgan Stanley | Overweight |
| Jul-15-19 | Initiated | Oppenheimer | Outperform |
View All
Personalis Inc Stock (PSNL) Latest News
Needham raises Personalis stock price target on takeover interest By Investing.com - Investing.com Canada
Why Is PSNL Stock Up 5% After-Hours? - Yahoo Finance
Personalis (PSNL) Recovers After Sale Speculation - GuruFocus
TD Cowen Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $18 - Moomoo
Form 4 Personalis Inc For: 15 July By Investing.com - Investing.com Nigeria
Personalis president and CMO Richard Chen sells $1.5m in stock - Investing.com
Personalis president and CMO Richard Chen sells $1.5m in stock By Investing.com - Investing.com India
Form 144 Personalis For: 15 July By Investing.com - Investing.com Nigeria
[144] Personalis, Inc. SEC Filing - Stock Titan
PERSONALIS INC : TD COWEN RAISES TARGET PRICE TO $18 FROM $10 - Moomoo
How UKCA Approval of NeXT Personal Dx Could Reshape Personalis’ (PSNL) Cross‑Border Cancer Trial Role - simplywall.st
Personalis receives UK regulatory clearance for cancer test - Investing.com
Personalis (PSNL) Secures UKCA Marking for NeXT Personal Dx Test - GuruFocus
Cancer Test for Small DNA Traces Can Now Be Used in Great Britain - Stock Titan
Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test - Stocktwits
PSNL Stock Climbs As Morgan Stanley Lifts Price Target - StocksToTrade
Personalis Inc. (PSNL) Surges Over 7% as Momentum Builds Above Key SupportTick Index - dars.gov.et
Enterprise value to EBITDA forward of Personalis, Inc. – HAM:04X - TradingView
Personalis's Clinical Growth Story Faces a Reality Check as CEO Sells Millions - Kavout | AI
Personalis Insider Sold Shares Worth $1,508,000, According to a Recent SEC Filing - Moomoo
Form 4 Personalis Inc For: 9 July By Investing.com - Investing.com Nigeria
Personalis CEO Christopher M. Hall sells $1.5m in common stock By Investing.com - Investing.com South Africa
Personalis CEO Christopher M. Hall sells $1.5m in common stock - Investing.com
Personalis (PSNL) CEO trades 100,000 shares via 10b5-1 plan and option exercise - Stock Titan
Form 144 Personalis For: 9 July By Investing.com - Investing.com South Africa
Morgan Stanley Smith Barney (PSNL) files Rule 144 to sell 100,000 shares on 07/09/2026 - Stock Titan
Personalis (PSNL) Stock Looks Rich Even After A Very Large Run - simplywall.st
PSNL Maintained by Morgan Stanley -- Price Target Raised to $13. - GuruFocus
Personalis, Inc. Stock 12‑Month Price Target Raised to $11.43, Implies 19% Downside - TradingView
Tracking Cathie Wood: Big Bet on SpaceX, Heavy Selling in Personalis and Gene-Sequencing Stocks - Moomoo
Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium - AOL.com
Personalis stock hits 52-week high at 14.24 USD - Investing.com
Personalis stock hits 52-week high at 14.24 USD By Investing.com - Investing.com South Africa
Q1 2025 Personalis Inc Earnings Call Transcript - GuruFocus
Q3 2025 Personalis Inc Earnings Call Transcript - GuruFocus
Personalis CFO and COO Aaron Tachibana sells $69,748 of stock. - Investing.com UK
Form 4 Personalis Inc For: 29 June By Investing.com - Investing.com Nigeria
Personalis CFO and COO Aaron Tachibana sells $69,748 of stock. By Investing.com - Investing.com Nigeria
Personalis (PSNL) CFO trades 4,982 shares under Rule 10b5-1 plan - Stock Titan
Personalis | 4: Statement of changes in beneficial ownership of securities-Officer Tachibana Aaron - Moomoo
PSNL (NASDAQ: PSNL) files Rule 144 to sell 4,982 shares via option exercise - Stock Titan
Personalis Inc. (PSNL) Shares Surge Over 5% as Momentum Builds Near Key ResistanceGap and Go - dars.gov.et
Personalis, Inc. Actuals & Estimates (SWB:04X) - TradingView
PSNL Technical Analysis & Stock Price Forecast - Intellectia AI
Form 144 Personalis For: 26 June By Investing.com - Investing.com Australia
Form 4 Personalis Inc For: 26 June By Investing.com - Investing.com India
Personalis CFO Aaron Tachibana sells $675,488 in company stock By Investing.com - Investing.com Nigeria
Personalis Inc Stock (PSNL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Personalis Inc Stock (PSNL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chen Richard | President and CMO |
Jul 15 '26 |
Sale |
15.15 |
100,000 |
1,515,000 |
173,880 |
3.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):